Assenagon Asset Management S.A. Harvard Bioscience Inc Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 139,220 shares of HBIO stock, worth $71,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares

139,220

Previous 36,801 278.3%

Holding current value

$71,002

Previous $16,000 268.75%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$0.4 - $0.57 $40,967 - $58,378	102,419 Added 278.3%	139,220 $59,000
Q2 2025 Jul 11, 2025	SELL	$0.28 - $0.69 $4,935 - $12,161	-17,625 Reduced 32.38%	36,801 $16,000
Q1 2025 Apr 15, 2025	SELL	$0.57 - $2.19 $8,762 - $33,666	-15,373 Reduced 22.02%	54,426 $31,000
Q4 2024 Jan 14, 2025	SELL	$2.02 - $2.82 $267,682 - $373,695	-132,516 Reduced 65.5%	69,799 $147,000
Q3 2024 Oct 23, 2024	SELL	$2.64 - $3.54 $67,019 - $89,866	-25,386 Reduced 11.15%	202,315 $544,000
Q2 2024 Jul 18, 2024	BUY	$2.77 - $4.63 $416,103 - $695,509	150,218 Added 193.87%	227,701 $648,000
Q4 2023 Jan 17, 2024	SELL	$4.0 - $5.49 $85,084 - $116,777	-21,271 Reduced 21.54%	77,483 $414,000
Q3 2023 Nov 06, 2023	SELL	$4.0 - $5.82 $143,584 - $208,914	-35,896 Reduced 26.66%	98,754 $424,000
Q2 2023 Jul 25, 2023	BUY	$4.19 - $6.16 $303,770 - $446,593	72,499 Added 116.65%	134,650 $739,000
Q1 2023 Apr 18, 2023	BUY	$2.45 - $4.22 $152,269 - $262,277	62,151 New	62,151 $261,000
Q3 2022 Oct 27, 2022	SELL	$2.33 - $3.92 $51,737 - $87,043	-22,205 Reduced 49.81%	22,377 $57,000
Q2 2022 Jul 27, 2022	BUY	$3.28 - $6.42 $45,687 - $89,424	13,929 Added 45.44%	44,582 $160,000
Q1 2022 Apr 25, 2022	SELL	$5.16 - $7.14 $490,132 - $678,207	-94,987 Reduced 75.6%	30,653 $190,000
Q4 2021 Feb 01, 2022	BUY	$6.37 - $8.18 $447,709 - $574,923	70,284 Added 126.97%	125,640 $886,000
Q3 2021 Oct 19, 2021	BUY	$6.98 - $8.47 $386,384 - $468,865	55,356 New	55,356 $386,000
Q3 2020 Oct 07, 2020	SELL	$2.75 - $4.2 $643,500 - $982,800	-234,000 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$2.12 - $3.14 $496,080 - $734,760	234,000 New	234,000 $725,000
Q4 2019 Jan 17, 2020	SELL	$2.45 - $3.25 $1.08 Million - $1.43 Million	-440,346 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$1.59 - $3.47 $679,532 - $1.48 Million	427,379 Added 3295.9%	440,346 $1.35 Million
Q2 2019 Aug 12, 2019	SELL	$1.93 - $4.59 $134,683 - $320,308	-69,784 Reduced 84.33%	12,967 $26,000
Q1 2019 Apr 26, 2019	BUY	$2.77 - $4.38 $229,220 - $362,449	82,751 New	82,751 $357,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

23.2M

Call Options Held

101K

Put Options Held

22K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $21.2M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Harvard Bioscience Inc Transaction History